JOINN Biologics Funding: $210M Raised, Series B (2021)

JOINN Biologics is based in Richmond. It has raised $210M in total funding. Latest round: Series B. Backed by CITIC PE, Huagai Capital, Green Pine Capital.

JOINN Biologics funding overview

JOINN Biologics is based in Richmond. JOINN Biologics has raised $210M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2021. The round record for JOINN Biologics runs through 2021; nothing later has been disclosed. Investors on record include CITIC PE, Huagai Capital, Green Pine Capital, Hongtai Aplus, Yingke Capital, HT Capital. 6 distinct backers are named across the disclosed rounds.

JOINN Biologics at a glance

Total raised
$210M
Latest round
Series B
Latest round date
August 2021
Headquarters
Richmond
Notable investors
CITIC PE, Huagai Capital, Green Pine Capital, Hongtai Aplus, Yingke Capital, HT Capital

Frequently asked about JOINN Biologics funding

How much has JOINN Biologics raised?
JOINN Biologics has raised $210M in total disclosed funding across the rounds on record.
Who has invested in JOINN Biologics?
CITIC PE, Huagai Capital, Green Pine Capital, Hongtai Aplus, Yingke Capital, HT Capital are named among the investors backing JOINN Biologics.
What was the latest JOINN Biologics funding round?
The most recent disclosed round is a Series B, announced in August 2021.
Where is JOINN Biologics based?
JOINN Biologics is based in Richmond.
When did JOINN Biologics last raise?
The last disclosed JOINN Biologics round closed in August 2021 at Series B.

Every JOINN Biologics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Richmond at a similar stage.

Companies related to JOINN Biologics (19)

Browse related funding lists (4)

Company funding database · Investor directory · Founder database · Mega-rounds 2026